SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.

Shenzhen Bioeasy Biotechnology Co., Ltd.

300942

CNE100004C78

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 14/07/2024 BST			5-day change	1st Jan Change
7.17 ^CNY	-0.83%		+4.37%	-38.67%

06-24	Shenzhen Bioeasy Biotechnology Co., Ltd.(XSEC:300942) dropped from S&P Global BMI Index	CI
05-14	Wang Tianyi completed the acquisition of 6.59% stake in Shenzhen Bioeasy Biotechnology Co., Ltd. from Bioeasy Venture Capital Co., Ltd., Zhu Hai and Shenzhen Yidarui Management Consulting Partnership Enterprise (Limited Partnership).	CI

Shenzhen Xiupu Biological Technology Co., Ltd. announced that it has received CNY 100 million in funding from Shenzhen Bioeasy Biotechnology Co., Ltd.

July 29, 2021

On July 30, 2021, Shenzhen Xiupu Biological Technology Co., Ltd. closed the transaction.

Latest news about Shenzhen Bioeasy Biotechnology Co., Ltd.

Shenzhen Bioeasy Biotechnology Co., Ltd.(XSEC:300942) dropped from S&P Global BMI Index	06-23	CI
Wang Tianyi completed the acquisition of 6.59% stake in Shenzhen Bioeasy Biotechnology Co., Ltd. from Bioeasy Venture Capital Co., Ltd., Zhu Hai and Shenzhen Yidarui Management Consulting Partnership Enterprise (Limited Partnership).	05-13	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-25	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Announces Executive Appointments	04-01	CI
Certain A Shares of Shenzhen Bioeasy Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-FEB-2024.	02-08	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
Bioeasy Joins Other Biotech Firms in Requesting to Cancel COVID-19 Test Kits	02/06/23	MT
Shenzhen Bioeasy Biotechnology Approves Cash Dividend for 2022, Payable on 31 May 2023	17/05/23	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Proposes Final Dividend for 2022	26/04/23	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/04/23	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Shenzhen Bioeasy Biotechnology Unit Gets Registration Certificates for Medical Devices	24/10/22	MT
Shenzhen Bioeasy Biotechnology Co., Ltd.(XSEC:300942) added to S&P Global BMI Index	19/09/22	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Announces Executive Appointments	16/08/22	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Approves Final Cash Dividend for the Year 2021, Payable on 30 May 2022	20/05/22	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Proposes Final Cash Dividend for the Year 2021	27/04/22	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	26/04/22	CI
Certain A Shares of Shenzhen Bioeasy Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-FEB-2022.	08/02/22	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/10/21	CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	25/08/21	CI

Chart Shenzhen Bioeasy Biotechnology Co., Ltd.

Duration

Period

Chart Shenzhen Bioeasy Biotechnology Co., Ltd.

More charts

Shenzhen Bioeasy Biotechnology Co Ltd is a China-based company mainly engaged in the research, development, production, sales and provision of food safety testing products and related services. The Companyâs main products are food safety rapid testing reagents, rapid testing instruments, related testing services and in vitro diagnostic point-of-car testing (POCT) products, such as colloidal gold immunochromatographic test papers, enzyme-linked immunoassay (ELISA) kits, nucleic acids extraction kit, portable food rapid analysis system, infectious disease detection series and fluorescence immunoassay analyzer, etc. Its products are mainly used in dairy, meat, aquatic products, grains and oils, fruits and vegetables and other food fields that require rapid testing, as well as in the cultivation and breeding fields.

Sector

Medical Equipment, Supplies & Distribution

Calendar

29/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.	-38.67%	396M
BIOMÉRIEUX	-7.06%	12.28B
LANTHEUS HOLDINGS, INC.	+96.32%	8.54B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-22.31%	6.58B
DIASORIN S.P.A.	+8.11%	5.77B
AUTOBIO DIAGNOSTICS CO., LTD.	-23.82%	3.48B
ANDON HEALTH CO., LTD.	+5.84%	2.54B
MYRIAD GENETICS, INC.	+42.61%	2.41B
VITROLIFE AB	-7.50%	2.3B
10X GENOMICS, INC.	-68.16%	2.07B